Showing 1 - 15 results of 15 for search 'S Libanati', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
Fracture Risk in Men and Women With Vertebral Fractures Identified Opportunistically on Routine Computed Tomography Scans and Not Treated for Osteoporosis: An Observational Cohort... by Michael Kriegbaum Skjødt, Joeri Nicolaes, Christopher Dyer Smith, Kim Rose Olsen, Cyrus Cooper, Cesar Libanati, Bo Abrahamsen
Published 2023-05-01
Article -
5
Imminent fracture risk assessments in the UK FLS setting: implications and challenges by Pinedo-Villanueva, R, Charokopou, M, Toth, E, Donnelly, K, Cooper, C, Prieto-Alhambra, D, Libanati, C, Javaid, M
Published 2019Journal article -
6
Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK by Pineda-Moncusí, M, El-Hussein, L, Delmestri, A, Cooper, C, Moayyeri, A, Libanati, C, Toth, E, Prieto-Alhambra, D, Khalid, S
Published 2022Journal article -
7
-
8
Extensive modeling-based bone formation after 2 months of romosozumab treatment: Results from the FRAME clinical trial by Erik F. Eriksen, Roland Chapurlat, Rogely Boyce, Jacques P. Brown, Stéphane Horlait, Cesar Libanati, Yifei Shi, Rachel B. Wagman, Pascale Chavassieux
Published 2020-10-01
Article -
9
The national treatment gap in secondary fracture prevention in Denmark 2005-2014: individual patient data including both hospital administered and all prescribed anti osteoporosis... by Skjødt, MK, Ernst, M, Abrahamsen, B, Khalid, S, Delmestri, A, Prieto-Alhambra, D, Libanati, C, Toth, E, Cooper, C, Martinez-Laguna, D
Published 2019Conference item -
10
Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a mutli-national study including data from Denmark, Spain, and the UK by Khalid, S, Ernst, M, Rubin, K, Martinez-Laguna, D, Delmestri, A, Javaid, K, Cooper, C, Libanati, C, Toth, E, Abrahamsen, B, Prieto-Alhambra, D
Published 2018Conference item -
11
Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom by Skjødt, MK, Khalid, S, Ernst, M, Rubin, KH, Martinez-Laguna, D, Delmestri, A, Javaid, MK, Cooper, C, Libanati, C, Toth, E, Abrahamsen, B, Prieto-Alhambra, D
Published 2020Journal article -
12
The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medicat... by Skjødt, MK, Ernst, MT, Khalid, S, Libanati, C, Cooper, C, Delmestri, A, Rubin, KH, Javaid, MK, Martinez-Laguna, D, Toth, E, Prieto-Alhambra, D, Abrahamsen, B
Published 2021Journal article -
13
Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial by Jacques P. Brown, Arkadi Chines, Roland Chapurlat, Joseph Foldes, Xavier Nogues, Roberto Civitelli, Tobias De Villiers, Fabio Massari, Cristiano Zerbini, Wenjing Yang, Chris Recknor, Cesar Libanati
Published 2020-10-01
Article -
14
Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models by Khalid, S, Pineda Moncusi, M, El‐Hussein, L, Delmestri, A, Ernst, M, Smith, C, Libanati, C, Toth, E, Javaid, MK, Cooper, C, Abrahamsen, B, Prieto‐Alhambra, D
Published 2021Journal article -
15
Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension. by S Papapoulos, Z Man, D Mellstrom, S Radominski, J-Y Reginster, H Resch, J Roman, S Roux, S Cummings, H Bone, R Chapurlar, M Brandi, J Brown, E Czerwinski, N Daizadeh, A Grauer, M-A Krieg, S Libanati
Published 2011-04-01
Article